Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy.
Matthew J EhrhardtQi LiuDaniel A MulrooneyIsaac B RheaStephanie B DixonJohn T LucasYadav SapkotaKyla C SheltonKristen K NessDeo Kumar SrivastavaAaron J McDonaldLeslie L RobisonMelissa M HudsonYutaka YasuiGregory T ArmstrongPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
GLS and NT-proBNP should be considered for improved identification of survivors at high risk for future cardiomyopathy.